KM Research Hub
DIGITIZATION RESULTS

KM 曲线提取结果

共 243 篇,按论文发表时间从新到旧排列。

论文发表日期KM Figure面板成功提取曲线数状态
Adjuvant icotinib for resected EGFR-mutated stage II-IIIA non-small-cell lung cancer (ICTAN, GASTO1002): a randomized comparison study.PMID 40866342 · Signal Transduct Target Ther 2025-Aug-28 2224 质量警告
The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.PMID 40851062 · BMC Cancer 2025-Aug-25 3111119 质量警告
Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study.PMID 40623279 · J Clin Oncol 2025-Aug-20 1668 质量警告
Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results.PMID 40127397 · Blood 2025-Aug-07 1225 质量警告
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial.PMID 40769977 · Signal Transduct Target Ther 2025-Aug-06 2222 质量警告
Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial.PMID 40067142 · Clin Cancer Res 2025-Aug-01 2224 提取完成
First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial.PMID 40440184 · Cancer Commun (Lond) 2025-Aug 1228 提取完成
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.PMID 40448579 · J Clin Oncol 2025-Aug 3557 质量警告
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial.PMID 40450141 · Nat Med 2025-Aug 2445 质量警告
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.PMID 40524338 · Br J Haematol 2025-Aug 1336 提取完成
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.PMID 40675873 · Eur Urol Oncol 2025-Aug 1226 质量警告
Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study.PMID 40683772 · EBioMedicine 2025-Aug 26615 质量警告
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial.PMID 40763412 · ESMO Open 2025-Aug 2224 提取完成
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study.PMID 40009500 · Blood 2025-Jul-31 1112 提取完成
The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy.PMID 40233321 · Blood 2025-Jul-31 1111 质量警告
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial.PMID 40580808 · Eur J Cancer 2025-Jul-25 26611 质量警告
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.PMID 40691143 · Nat Commun 2025-Jul-21 2559 质量警告
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.PMID 40513032 · N Engl J Med 2025-Jul-17 1112 提取完成
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915.PMID 40645660 · J Immunother Cancer 2025-Jul-11 3111136 质量警告
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.PMID 40408605 · J Clin Oncol 2025-Jul-10 1224 提取完成
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM.PMID 38420778 · Ann Surg 2025-Jul-01 26612 质量警告
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer.PMID 40215429 · J Clin Oncol 2025-Jul 2448 提取完成
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial.PMID 40293644 · Breast Cancer Res Treat 2025-Jul 1335 质量警告
Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial.PMID 40379995 · Nat Med 2025-Jul 1224 提取完成
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.PMID 40408613 · J Clin Oncol 2025-Jul 36611 质量警告
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial.PMID 40467898 · Nat Med 2025-Jul 2435 部分完成
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.PMID 40590325 · J Gynecol Oncol 2025-Jul 2448 提取完成
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.PMID 40632974 · JCO Precis Oncol 2025-Jul 25516 提取完成
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer.PMID 40444708 · N Engl J Med 2025-Jun-26 2226 提取完成
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2- advanced breast cancer: Final results of the randomized phase III MONARCH plus trial.PMID 39385327 · Chin Med J (Engl) 2025-Jun-20 2447 质量警告